Skip to main content

Full text of "USPTO Patents Application 09848616"

See other formats


Q Sterne Kessler 
Goldstein Fox 

ATTORNEYS AT LAW 



Robert Greene Sterne 
Edward J. Kessler 
Jorge A. Goldstein 
David K.S. Comwell 
Robert W.Esmond 
Tracy-Gene G. Durton 
Micnele A. Cimbala 
Michael B. Ray 
Robert E. Sokohl 
Eric K. Steffe 
Michael Q. Lee 
Steven R. Ludwig 
John M. Covert 
Unda E. Alcorn 
Robert C Millonig 
Lawrence B. Bugaisky 
Donald J. Featherstone 
Michael V. Messinger 
Judith U. Kim 
Timothy J. Shea, Jr. 



Patrick E. Garrett 
JefferyT.Helvey* 
Heidi L Kraus 
Crystal D. Sayles 
Edward W.Yee 
Albert L Ferro* 
Donald R. Banowit 
Peter A. Jadcman 
Molly A. McCall 
Teresa U. Medler 
Jeffrey S. Weaver 
Kendridc P. Patterson 
Vincent L. Capuano 
Albert J. Fasulo II* 
Eldora Ellison Floyd 
W. Russell Swindell 
Thomas C. Fiala 
Brian J. Del Buono* 
Virgil Lee Beaston* 
Reginald D. Lucas* 



May 7, 2002 



Kimberiy N. Reddtck 
Theodore A. Wood 
Elizabeth J. Haanes 
Bruce E. Chatter 
Joseph S. Ostroff 
Frank R. Cottingham* 
Christine M. Lhulier 
Rae Lynn Prengaman* 
Jane Shershenovich* 
Lawrence I. Carroll* 
George S. Bardmesser 

Senior Counsel 
Samuel L. Fox 
Kenneth C. Bass 111 

Registered Patent Aoents 
Karen R. Maricowia 
Andrea J. Kamage 



fJ.Leitff - ' * 
h M. ConractUT) ■ JJ 



Nam 
Jose; 

Ann E. Summerfi^l _ 
Helene C Carbon 
Gaby L. LonqswottH* 
Matthew J. DowdD* 
Aaron L. Schwar&~< 
Anqelique G. Uy 
BonsA. Matvenko 1 
Mary B. Tung 
KatnnaY.Pei 
Bryan L Skelton „ . 
Jason D. EisenbecgH 
Alicia M. Choi — • 



irv ijMjrylai 

* Admitted only inwginia 

* Admitted only irffBcas 



Ho 



O 



Writer 's Direct Number: 

(202)789-5525 

Internet Address: 

BRIAND@SKGF.COM 



Commissioner for Patents 
Washington, D.C. 20231 



Sir: 



Via Hand Carry 
To Art Unit 1645 



X 



Re: U.S. Utility Patent Application 

Appl. No. 09/848,616; Filed: May 4, 2001 4fy 
For: Molecular Antigen Array ^> $ ^\ 

Inventors: Sebbel etal. 

OurRef: 1700.0 180002/JAG/BJD ^> ^ 

% 

Transmitted herewith for appropriate action are the following documents: 

1. Information Disclosure Statement; 

2. 35 pages of Form PTO-1449 citing 136 documents; 

3. A copy of each of the 136 cited documents; and 

4. One (1) return postcard. 

It is respectfully requested that the attached postcard be stamped with the date of filing of 
these documents, and that it be returned to our courier. In the event that extensions of time are 
necessary to prevent abandonment of this patent application, then such extensions of time are 
hereby petitioned. 



Sterne, Kessler, Goldstein & Fox p.llc : 1100 New York Avenue, NW : Washington, DC 20005 : 202.371.2600 f 202.371.2540 : www.skgf.com 



Commissioner for Patents 
May 7, 2002 
Page 2 

The U.S. Patent and Trademark Office is hereby authorized to charge any fee deficiency, 
or credit any overpayment, to our Deposit Account No. 19-0036. 



SKGF_DC1:11430.1 



Sterne, Kessler, Goldstein & Fox p.llc. : 1100 New York Avenue, NW : Washington, DC 20005 : 202.371.2600 f 202.371,2540 : www.skgf.com 



Respectfully submitted, 



Sterne, Kessler, Goldstein & Fox p.l.l.c. 




Brian J. Del Buono 
Attorney for Applicants 
Registration No. 42,473 



BJD/nef 
Enclosures 



IN THE UNITED STATES PATENT AND TRADEMARK OFFldg ~ 



In re application of: 

Sebbel et al 
Appl. No. 09/848,616 
Filed: May 4, 2001 
For: Molecular Antigen Array 



~~< - TO 



Confirmation No. 601 8 
Art Unit: 1645 ^ 

Examiner: 7b Z>e assignee^ 

Atty. Docket: 1 700.0 180002/JAG/BJ& 



Information Disclosure Statement 

Commissioner for Patents 



Washington, D.C. 20231 



32, 



Sir: ^% 

Listed on accompanying Form PTO-1449 are documents that may be considered 
material to the examination of this application, in compliance with the duty of disclosure 
requirements of 37 C.F.R. §§ 1 .56, 1 .97 and 1 .98. A copy of each of these documents is 
provided. 

Where the publication date of a listed document does not provide a month of 
publication, the year of publication of the listed document is sufficiently earlier than the 
effective U.S. filing date and any foreign priority date so that the month of publication is 
not in issue. Applicants have listed publication dates on the attached PTO-1449 based on 

* 

information presently available to the undersigned. However, the listed publication dates 
should not be construed as an admission that the information was actually published on 
the date indicated. 

Applicants note that Document No. AL2, cited on the accompanying Form PTO- 
1449, is a non-English language PCT application. In accordance with 
M.P.E.P. § 609 III.A(3), Applicants submit herewith Document No. AA2, which issued 



- 2 - Sebbel et al 

Appl.No. 09/848,616 

from a U.S. National phase application based on Document No. AL2. Thus, Applicants 
believe that Document No. AA2 is an English language equivalent of Document No. 
AL2, and that no further concise explanation is required. See M.P.E.P. § 609 III.A(3) 
(August 2001). 

The Examiner is referred to the following list of related, co-pending patent 
applications: 

U.S. Patent Application No. 10/050,902, filed January 18, 2002, inventors Renner 
et al. 9 submitted herewith as Document AT34; 

U.S. Patent Application No. 10/050,898, filed January 18,2002, inventors Renner 
et aL 9 submitted herewith as Document AR35. 

The identification of these U.S. Patent Applications is not to be construed as a 
waiver of secrecy as to these applications now or upon issuance of the present application 
as a patent. The Examiner is respectfully requested to consider the cited applications and 
the art cited therein during examination. 

Applicants reserve the right to establish the patentability of the claimed invention 
over any of the information provided herewith, and/or to prove that this information may 
not be prior art, and/or to prove that this information may not be enabling for the 
teachings purportedly offered. 

This statement should not be construed as a representation that a search has been 
made, or that information more material to the examination of the present patent 
application does not exist. The Examiner is specifically requested not to rely solely on 
the material submitted herewith. It is further understood that the Examiner will consider 



-3- 



Sebbel et al 
Appl.No. 09/848,616 



information that had been cited or submitted to the U.S. Patent and Trademark Office in 
a prior application relied on under 35 U.S.C. § 120. 1 138 OG 37, 38 (May 19, 1992). 

It is respectfully requested that the Examiner initial and return a copy of the 
enclosed PTO-1449, and to indicate in the official file wrapper of this patent application 
that the documents have been considered. 

This Information Disclosure Statement is being filed more than three months after 
the U.S. filing date, but before the mailing date of a first Office Action on the merits. No 
statement or fee is required. 

The U.S. Patent and Trademark Office is hereby authorized to charge any fee 
deficiency, or credit any overpayment, to our Deposit Account No. 19-0036. 



Respectfully submitted, 



Sterne, Kessler, Goldstein & Fox p.l.l.c. 



Brian Del Buono 
Attorney for Applicants 
Registration No. 42,473 





1 100 New York Avenue, N.W. 
Suite 600 

Washington, D.C. 20005-3934 
(202)371-2600 



SKGFJDC 1:9832.1